CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement

October 15, 2024 8:00 AM

CBD Life Sciences propels its expansion with a major MOU, positioning the company for multi-million-dollar growth in the booming $14.6 billion adaptogens market.SCOTTSDALE, AZ / ACCESSWIRE / October 15, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL) is excited to announce the signing of a game-changing Memorandum of Understanding (MOU) with a division of the United States Armed Forces, marking a pivotal moment in the company's journey toward...

Read more

Revival Health Inc. Partners With BSS Health to Bring Affordable GLP-1 Obesity Medication to Mississippians Following Policy Change at Mississippi Board of Medical Licensure

October 15, 2024 8:00 AM

In partnership with statewide health clinics and organizations, Revival Health and former Governor Phil Bryant join forces to tackle Mississippi's growing public health crisis-obesity-through the Mississippi Obesity Alliance Program.JACKSON, MS / ACCESSWIRE / October 15, 2024 / Revival Health Inc. proudly announces the launch of the Mississippi Obesity Alliance Program (MOA)to combat the state's growing obesity epidemic. Approximately 1 in 3...

Read more

TRIANA Biomedicines and Pfizer Enter Into A Research Collaboration to Discover Novel Molecular Glue Degraders for Multiple Disease Areas

October 15, 2024 8:00 AM

TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused on building a target-first molecular glue discovery pipeline for inactivating difficult to address disease targets, announced today that it has entered into a strategic collaboration and licensing agreement with Pfizer to discover novel molecular glue degraders for multiple targets in several disease areas, including oncology."We are thrilled to partner with Pfizer...

Read more

Perceiv AI Welcomes Simona Skerjanec to Board of Directors

October 15, 2024 7:00 AM

Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision MedicineMONTREAL, QC / ACCESSWIRE / October 15, 2024 / Perceiv AI, a leading precision medicine company pioneering disease forecasting to transform clinical trials and redefine tomorrow's care is pleased to announce the appointment of Simona Skerjanec, M.Pharm, MBA, a thought leader in brain health with decades of experience in drug...

Read more

NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules

October 15, 2024 7:00 AM

ZURICH, SWITZERLAND / ACCESSWIRE / October 15, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced the closing of a private placement offering consisting of the issuance and sale of 806,452 common shares, par value CHF...

Read more

NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology

October 15, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, was interviewed in a podcast by the PODD Conference* host. The podcast was published on October 11, 2024, on PharmaTalkRadio.The interview can be viewed at the PODD website at...

Read more

Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference

October 15, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / October 15, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced its sponsorship of educational programs at the upcoming Fetch Coastal, formerly the Atlantic Coast Veterinary Conference, in Atlantic City, NJ from October 14-16 , 2024."The Fetch Coastal conference...

Read more

Senzime to launch Next-Generation TetraGraph System at ANESTHESIOLOGY 2024 Conference

October 15, 2024 4:20 AM

UPPSALA, SE / ACCESSWIRE / October 15, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB, a leader in perioperative patient monitoring solutions, announces the launch of its next-generation TetraGraph system at the annual ANESTHESIOLOGY 2024 conference commencing on October 18th, 2024, in Philadelphia, USA.The next-generation TetraGraph is designed to redefine the standards of quantitative train-of-four (TOF) monitoring and enhance patient...

Read more

Innovations in Blood Banking Equipment Market Growth Valuation Estimated at USD 25,591.4 Million in 2034 with a 4.6% of CAGR | Future Market Insights, Inc.

October 15, 2024 2:50 AM

The global Blood Banking Equipment Market is projected to experience substantial growth over the forecast period from 2024 to 2034. In 2024, the market is expected to be valued at USD 16,322.1 million and is anticipated to grow at a compound annual growth rate (CAGR) of 4.6%, reaching USD 25,591.4 million by 2034. This growth can be attributed to the increasing demand for efficient blood collection, processing, and storage systems, as well as...

Read more

Families Step Confidently Through Their Perinatal Journey: Happy Mama Expo 2024 Unveils New Innovative Digital Service Line

October 14, 2024 6:50 PM

Happy Mama Expo 2024 is on Saturday, October 19, 2024, from 7:00 a.m. to 7:00 p.m. Eastern.SAN DIEGO, CA / ACCESSWIRE / October 14, 2024 / Those on their unique journey of motherhood are gearing up for the Happy Mama Expo 2024, where every stage of pregnancy and early parenthood is celebrated. Experience it for yourself on Saturday, October 19, under the vibrant theme, "Finding Your Groove," to discover your rhythm and embrace the transformative...

Read more

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

October 14, 2024 4:15 PM

DENVER, CO / ACCESSWIRE / October 14, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced Josh Disbrow, Chief Executive Officer of Aytu, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16, 2024, at 2:00 p.m. Eastern time.2024 Maxim Healthcare Virtual Summit DetailsFormat: Fireside...

Read more

Impetus One: PracticeSYNC Revolutionizes Healthcare with Cutting-Edge Technology

October 14, 2024 1:00 PM

Impetus One is leading the charge in healthcare innovation with the launch of PracticeSYNC, a versatile software platform designed to elevate the way healthcare providers deliver patient care.In an era where both telehealth and traditional practices are evolving, PracticeSYNC offers a next-generation solution that seamlessly integrates advanced technologies to transform patient engagement and operational efficiency.A New Era of Healthcare...

Read more

Icovy Marketing and Chamfr Form Strategic Partnership to Empower Medtech Suppliers

October 14, 2024 10:15 AM

SALT LAKE CITY, UT / ACCESSWIRE / October 14, 2024 / Icovy Marketing, a leading medtech marketing agency, and Chamfr, a marketplace connecting medtech innovators globally with essential components, solutions, and suppliers, announced a strategic partnership aimed at accelerating growth for medical device suppliers by combining their digital marketing expertise, industry relationships, and Chamfr's platform.This collaboration brings together the...

Read more

Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention

October 14, 2024 10:00 AM

NEW YORK, NY / ACCESSWIRE / October 4, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation of advanced oral drug delivery systems, announced today its participation in the 2024 BIO-Europe Convention from November 4-6, 2024 in Stockholm, Sweden.This year at BIO-Europe, Laxxon Medical is showcasing its LXM.2 asset, a non-invasive, once-a-day 3D printed oral GLP-1 Agonist treatment for weight loss. Laxxon is...

Read more

Sygnity Wellness Launches New Website to Meet Growing Demand for Online Health Information

October 14, 2024 9:00 AM

WEST PALM BEACH, FL / ACCESSWIRE / October 14, 2024 / Responding to the significantly increased demand for accessible mental health resources, Sygnity Wellness has launched a new website designed to make virtual therapy more accessible to everyone. With innovative features that simplify connecting with therapists and managing sessions online, this initiative addresses the needs of individuals balancing their personal and professional lives. The...

Read more

Medical Mask Market Production and Adoption Aims for USD 16,780.20 Million Market Valuation by 2034 at a 10.80% of CAGR | Future Market Insights, Inc.

October 14, 2024 3:10 AM

The medical mask market demand 2024 to 2034 is set for significant growth, driven by rising healthcare demands, stringent regulatory requirements, and increasing awareness of health safety among individuals. As healthcare infrastructure expands globally, and infection control becomes a higher priority, the demand for medical masks is expected to escalate, with the market size projected to grow from USD 6,017.30 million in 2024 to USD 16,780.20...

Read more

Notice of Extraordinary General Meeting in PMD Device Solutions AB (Publ)

October 14, 2024 1:20 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / October 14, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) By demand from Miman Ventures AB, a shareholder controlling more than 10 percent of the total shares in the Company, the shareholders of PMD Device Solutions AB (publ), reg. no. 556639-6809 (the "Company"), are hereby invited to an extraordinary general meeting on 29 October 2024 at 11:00 CET at the premises of Eversheds Sutherland located at Sveavägen...

Read more

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 11, 2024 4:15 PM

SAN FRANCISCO, CA / ACCESSWIRE / October 11, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective October 7, 2024, the Company granted 80,000 restricted stock units (RSUs) to New Employee 1 and 15,000 RSUs to each of four other new employees ("New Employees 2-5").The RSUs for New Employee 1 vest equally over three years, with one-third of the shares vesting each year starting from New Employee 1's...

Read more

CARE Joins Global Movement To Eliminate Gender Bias in Advertising and Entertainment

October 11, 2024 11:15 AM

ATLANTA, GA and NEW YORK, NY / ACCESSWIRE / October 11, 2024 / CARE is thrilled to join SeeHer, the largest global movement to eliminate gender bias in advertising and entertainment, as its newest and first-ever nonprofit member. Earlier this year, CARE received the Category Grand Prize at SeeHer's 2024 Gender Equality Measure (GEM) Awards. The recognition, which exemplifies the best-in-class accurate and authentic portrayal of women and girls...

Read more

Gary Payton THCA Flower Strain: Black Tie CBD's New High-Potency Hemp Delight

October 11, 2024 7:45 AM

RALEIGH, NC / ACCESSWIRE / October 11, 2024 / Black Tie CBD proudly introduces the Gary Payton THCA Flower, an indoor-grown hemp strain that stands out as a new high-potency delight for cannabis enthusiasts. Named after the legendary NBA player, this strain is as dynamic and impactful as its namesake, offering a remarkable combination of potency, flavor, and aroma that sets a new standard in hemp flower excellence. Meticulously cultivated...

Read more